RA Capital Nexus Fund, L.P.
Insider CIK 1780117 · BDTX Director · SLDB Director, 10% owner · AKUS 10% owner · ELYM Director, 10% owner · ETNB Director, 10% owner · ICVX Director, 10% owner · NKTX Director, 10% owner · AVTE Director, 10% owner · VOR Director, 10% owner · ARTV Director · TYRA Director, 10% owner · FRNM Director · SION Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 40,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.00 | $30.0K | 20,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 40,000 | $1.29 | $51.6K | 70,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $7.89 | $78.9K | 30,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 40,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 40,000 | $1.29 | $51.6K | 70,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $7.89 | $78.9K | 30,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.00 | $30.0K | 20,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy deriv | 2026-09-15 | 2026-09-17 | 9,078,529 | $22.03 | $200.00M | 11,616,986 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy deriv | 2026-09-15 | 2026-09-17 | 9,078,529 | $22.03 | $199.99M | 11,616,986 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-31 | 2026-07-31 | 24,944 | $9.93 | $247.7K | 17,329,570 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-31 | 2026-07-31 | 24,944 | $9.93 | $247.7K | 17,329,570 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-29 | 2026-07-31 | 20,824 | $9.99 | $208.0K | 17,304,626 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-29 | 2026-07-31 | 20,824 | $9.99 | $208.0K | 17,304,626 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-24 | 2026-07-28 | 41,319 | $9.99 | $412.8K | 17,283,802 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-24 | 2026-07-28 | 41,319 | $9.99 | $412.8K | 17,283,802 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-23 | 2026-07-23 | 59,880 | $9.96 | $596.4K | 17,242,483 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-22 | 2026-07-23 | 84,124 | $9.93 | $835.4K | 17,182,603 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-21 | 2026-07-23 | 120,582 | $9.55 | $1.15M | 17,098,479 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 336,965 | $10.00 | $3.37M | 1,245,068 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 4,918,411 | $10.00 | $49.18M | 12,230,122 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 367,427 | — | $0 | 367,427 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 908,103 | — | $0 | 908,103 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 553,703 | — | $0 | 553,703 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 970,950 | — | $0 | 970,950 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 6,561,711 | — | $0 | 7,311,711 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-17 | 2026-07-20 | 7,882 | $8.95 | $70.5K | 16,977,927 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-16 | 2026-07-20 | 152,472 | $8.93 | $1.36M | 16,970,045 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-13 | 2026-07-14 | 6,552 | $8.94 | $58.6K | 16,817,573 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-13 | 2026-07-23 | 6,522 | $8.94 | $58.3K | 16,817,543 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-10 | 2026-07-14 | 15,102 | $8.97 | $135.5K | 16,811,021 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-29 | 2026-07-01 | 70,284 | — | $0 | 70,284 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-26 | 2026-06-29 | 1,876 | $8.98 | $16.8K | 16,795,919 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-25 | 2026-06-29 | 31,000 | $8.88 | $275.3K | 16,794,043 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-16 | 2026-06-16 | 124,893 | $8.89 | $1.11M | 16,763,043 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-15 | 2026-06-16 | 15,414 | $8.99 | $138.6K | 16,638,150 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-12 | 2026-06-16 | 391,019 | $8.57 | $3.35M | 16,622,736 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-11 | 2026-06-11 | 548,580 | $7.91 | $4.34M | 16,231,717 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-10 | 2026-06-11 | 103 | $7.00 | $721 | 15,683,137 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-09 | 2026-06-11 | 479,039 | $6.91 | $3.31M | 15,683,034 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2026-05-28 | 2026-06-01 | 13,160 | — | $0 | 13,160 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy deriv | 2026-05-11 | 2026-05-13 | 2,170,138 | $11.52 | $25.00M | 2,170,138 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-05-11 | 2026-05-13 | 6,510,416 | $11.52 | $75.00M | 15,203,995 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-04-29 | 2026-04-29 | 2,106,000 | $9.50 | $20.01M | 22,546,000 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2026-01-05 | 2026-01-07 | 7,111 | $3.50 | $24.9K | 3,403,429 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2025-12-12 | 2025-12-15 | 101,462 | $2.86 | $290.2K | 3,396,318 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-12-11 | 2025-12-15 | 20,440,000 | — | $0 | 20,440,000 | SEC↗ |
| CLYM Climb Bio, Inc. | D To issuer | 2025-12-11 | 2025-12-15 | 20,440,000 | — | $0 | 3,081,757 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2025-12-11 | 2025-12-15 | 213,099 | $2.18 | $464.6K | 3,294,856 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 6,440 | $39.50 | $254.4K | 2,198,082 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 9,924 | $39.50 | $392.0K | 650,307 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 1,210 | $39.50 | $47.8K | 6,897,623 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 7,609 | $39.50 | $300.6K | 159,033 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 788 | $40.50 | $31.9K | 660,231 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 604 | $40.50 | $24.5K | 166,642 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 512 | $40.50 | $20.7K | 2,204,522 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 96 | $40.50 | $3.9K | 6,898,833 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 947 | $39.89 | $37.8K | 167,246 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 801 | $39.89 | $32.0K | 2,205,034 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 1,235 | $39.89 | $49.3K | 661,019 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 150 | $39.89 | $6.0K | 6,898,929 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 2,276 | $40.01 | $91.1K | 6,899,081 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 18,684 | $40.01 | $747.5K | 662,266 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 12,126 | $40.01 | $485.2K | 2,205,843 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 14,325 | $40.01 | $573.1K | 168,202 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 2 | $40.61 | $81 | 6,899,079 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 12 | $40.61 | $487 | 662,254 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 8 | $40.61 | $325 | 2,205,835 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 9 | $40.61 | $365 | 168,193 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 2,092 | $39.57 | $82.8K | 182,527 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 332 | $39.57 | $13.1K | 6,901,357 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 2,728 | $39.57 | $107.9K | 680,950 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 1,770 | $39.57 | $70.0K | 2,217,969 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 2,182 | $40.20 | $87.7K | 6,903,443 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 17,913 | $40.20 | $720.1K | 698,075 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 11,626 | $40.20 | $467.4K | 2,229,082 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 13,734 | $40.20 | $552.1K | 195,657 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 1,701 | $41.05 | $69.8K | 6,901,742 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 13,964 | $41.05 | $573.2K | 684,111 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 9,063 | $41.05 | $372.0K | 2,220,019 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 10,707 | $41.05 | $439.5K | 184,950 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 331 | $42.10 | $13.9K | 184,619 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 280 | $42.10 | $11.8K | 2,219,739 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 433 | $42.10 | $18.2K | 683,678 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 53 | $42.10 | $2.2K | 6,901,689 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 12,500 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 45,150 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 27,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 25,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 4,331,081 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer | 2025-10-30 | 2025-11-03 | 335,364 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer | 2025-10-30 | 2025-11-03 | 19,554,319 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 31,392 | $39.58 | $1.24M | 715,988 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 17,118 | $39.58 | $677.5K | 2,240,708 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 10,476 | $39.58 | $414.6K | 209,391 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 3,624 | $39.58 | $143.4K | 6,905,625 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 14,116 | $39.50 | $557.6K | 6,909,249 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 107,941 | $39.50 | $4.26M | 219,867 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 122,271 | $39.50 | $4.83M | 747,380 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 66,672 | $39.50 | $2.63M | 2,257,826 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-21 | 2025-10-22 | 25,027 | $28.11 | $703.5K | 1,401,226 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 6,553 | $30.12 | $197.4K | 1,426,253 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 1,287 | $30.12 | $38.8K | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 70,366 | $29.63 | $2.08M | 1,432,806 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 13,817 | $29.63 | $409.4K | 1,287 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 174,594 | $29.12 | $5.08M | 1,546,621 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 2,492 | $31.00 | $77.3K | 15,104 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 12,691 | $31.00 | $393.4K | 1,503,172 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 6,040 | $30.28 | $182.9K | 17,596 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 30,758 | $30.28 | $931.4K | 1,515,863 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 34,284 | $29.12 | $998.4K | 23,636 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 111,041 | $29.32 | $3.26M | 1,737,061 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 21,804 | $29.32 | $639.3K | 61,032 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 15,826 | $30.36 | $480.5K | 1,721,235 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 3,108 | $30.36 | $94.4K | 57,924 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 20 | $31.35 | $627 | 1,721,215 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 4 | $31.35 | $125 | 57,920 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-15 | 2025-10-17 | 234 | $31.17 | $7.3K | 1,848,102 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-15 | 2025-10-17 | 46 | $31.17 | $1.4K | 82,836 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-15 | 2025-10-17 | 42,699 | $30.55 | $1.30M | 1,848,336 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-15 | 2025-10-17 | 8,384 | $30.55 | $256.1K | 82,882 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-09-18 | 2025-09-22 | 10,000,000 | $5.00 | $50.00M | 10,000,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-09-08 | 2025-09-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2025-06-24 | 2025-06-26 | 13,750 | — | $0 | 13,750 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2025-06-16 | 2025-06-16 | 11,813 | $10.13 | $119.7K | 10,259,291 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2025-06-13 | 2025-06-16 | 120,167 | $10.20 | $1.23M | 10,247,478 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2025-06-12 | 2025-06-16 | 31,307 | $10.20 | $319.3K | 10,127,311 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2025-06-09 | 2025-06-11 | 186,850 | $10.19 | $1.90M | 10,096,004 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 46,000 | — | $0 | 46,000 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2025-06-05 | 2025-06-06 | 213,334 | $10.04 | $2.14M | 9,909,154 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2025-06-04 | 2025-06-06 | 997,864 | $9.63 | $9.61M | 9,695,820 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 22,200 | — | $0 | 22,200 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,155,469 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 4,364,874 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 124,908 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 923,773 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,091,219 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 451,580 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,229,830 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 819,153 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 319,069 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 138,054 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | P Buy | 2025-02-10 | 2025-02-10 | 102,414 | $18.00 | $1.84M | 2,324,498 | SEC↗ |
| SION Sionna Therapeutics, Inc. | P Buy | 2025-02-10 | 2025-02-10 | 1,022,586 | $18.00 | $18.41M | 6,923,365 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 179,975 | — | $0 | 327,808 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 2,222,084 | — | $0 | 2,222,084 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 5,021,990 | — | $0 | 5,900,779 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 527,444 | — | $0 | 869,651 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2025-01-30 | 2025-02-03 | 5,714,285 | $8.75 | $50.00M | 19,554,319 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2024-12-30 | 2024-12-30 | 21,121,449 | — | $0 | 21,121,449 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award | 2024-12-30 | 2024-12-30 | 16,897,159 | — | $0 | 37,820,713 | SEC↗ |
| ETNB 89bio, Inc. | P Buy deriv | 2024-11-14 | 2024-11-18 | 3,250,000 | $8.50 | $27.63M | 4,331,081 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2024-11-08 | 2024-11-13 | 1,220,681 | $16.25 | $19.84M | 8,697,956 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | J Other deriv | 2024-10-18 | 2024-10-22 | 2,358,457 | — | $0 | 1,000,000 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | J Other | 2024-10-18 | 2024-10-22 | 1,000,000 | — | $0 | 7,477,275 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 68,320 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 210,898 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 53,673 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 161,019 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 564,372 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 323,181 | $10.20 | $3.30M | 1,048,572 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 725,391 | — | $0 | 725,391 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 264,571 | — | $0 | 264,571 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-24 | 688,326 | $12.00 | $8.26M | 826,832 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-24 | 7,645,007 | $12.00 | $91.74M | 8,693,579 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 138,506 | $10.20 | $1.41M | 138,506 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 68,320 | — | $0 | 68,320 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | P Buy | 2024-06-27 | 2024-07-01 | 1,059,375 | $3.84 | $4.07M | 2,866,375 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | P Buy | 2024-06-27 | 2024-07-01 | 11,949,171 | $3.84 | $45.88M | 23,521,757 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award | 2024-06-27 | 2024-07-01 | 973,000 | — | $0 | 11,572,586 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award | 2024-06-27 | 2024-07-01 | 1,807,000 | — | $0 | 1,807,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award | 2024-06-27 | 2024-07-01 | 2,479,872 | — | $0 | 2,479,872 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | P Buy | 2024-06-17 | 2024-06-20 | 928,110 | $1.67 | $1.55M | 7,893,678 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 22,500 | — | $0 | 22,500 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2024-05-29 | 2024-05-31 | 18,600 | — | $0 | 18,600 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ETNB 89bio, Inc. | X Exercise deriv | 2024-04-11 | 2024-04-15 | 2,816,900 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | X Exercise | 2024-04-11 | 2024-04-15 | 1,408,450 | $5.33 | $7.51M | 13,840,034 | SEC↗ |
| NKTX Nkarta, Inc. | P Buy deriv | 2024-03-27 | 2024-03-29 | 3,000,031 | $10.00 | $30.00M | 3,000,031 | SEC↗ |
| NKTX Nkarta, Inc. | P Buy | 2024-03-27 | 2024-03-29 | 3,000,000 | $10.00 | $30.00M | 10,050,818 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2024-03-04 | 2024-03-06 | 1,350,000 | $15.35 | $20.72M | 12,431,584 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2024-02-06 | 2024-02-08 | 1,538,457 | $13.01 | $20.02M | 1,538,457 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2024-02-06 | 2024-02-08 | 3,180,155 | $13.01 | $41.37M | 8,477,275 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-02-01 | 2024-04-15 | 45,150 | — | $0 | 45,150 | SEC↗ |
| SLDB Solid Biosciences Inc. | P Buy | 2024-01-11 | 2024-01-12 | 904,160 | $5.53 | $5.00M | 4,192,216 | SEC↗ |
| ETNB 89bio, Inc. | P Buy deriv | 2023-12-11 | 2023-12-13 | 1,081,081 | $9.25 | $10.00M | 1,081,081 | SEC↗ |
| BDTX Black Diamond Therapeutics | P Buy | 2023-07-05 | 2023-07-07 | 935,850 | $5.00 | $4.68M | 3,213,828 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ICVX Icosavax, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 9,650 | — | $0 | 9,650 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2023-05-31 | 2023-06-02 | 14,500 | — | $0 | 14,500 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2023-03-24 | 2023-03-30 | 2,461,538 | $16.25 | $40.00M | 11,081,584 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2023-02-09 | 2024-04-15 | 27,400 | — | $0 | 27,400 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-13 | 2022-12-15 | 9,650 | — | $0 | 9,650 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-05 | 2,163,120 | $7.05 | $15.25M | 2,987,644 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-05 | 300,412 | — | $0 | 3,288,056 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-05 | 109,661 | — | $0 | 109,661 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2022-10-18 | 2022-10-20 | 1,172,741 | $7.65 | $8.97M | 8,955,410 | SEC↗ |
| ETNB 89bio, Inc. | P Buy deriv | 2022-07-01 | 2022-07-06 | 2,816,900 | — | $0 | 1,408,450 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2022-07-01 | 2022-07-06 | 2,816,900 | $3.55 | $10.00M | 7,782,669 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2022-06-21 | 2022-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 14,500 | — | $0 | 14,500 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2022-05-16 | 2022-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NKTX Nkarta, Inc. | P Buy | 2022-04-26 | 2022-04-28 | 2,200,000 | $15.00 | $33.00M | 7,805,129 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 170,448 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 393,940 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 1,011,370 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 546,773 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 182,257 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 4,047,120 | — | $0 | 4,047,120 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2021-09-17 | 2021-09-17 | 1,250,000 | $16.00 | $20.00M | 5,297,120 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 1,496,613 | — | $0 | 1,496,613 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 442,721 | — | $0 | 442,721 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 708,333 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 673,076 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 1,415,002 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 2,639,507 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 139,481 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 485,493 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 288,461 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion deriv | 2021-08-12 | 2021-08-16 | 518,164 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion | 2021-08-12 | 2021-08-16 | 288,461 | — | $0 | 288,461 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion | 2021-08-12 | 2021-08-16 | 4,727,585 | — | $0 | 7,594,804 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion | 2021-08-12 | 2021-08-16 | 624,974 | — | $0 | 841,087 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | P Buy | 2021-08-12 | 2021-08-16 | 195,218 | $12.50 | $2.44M | 483,679 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | C Conversion | 2021-08-12 | 2021-08-16 | 1,226,497 | — | $0 | 1,226,497 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | P Buy | 2021-08-12 | 2021-08-16 | 3,004,782 | $12.50 | $37.56M | 10,599,586 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2021-08-09 | 2021-08-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 8,232,679 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 3,066,397 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 966,506 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 4,000,000 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion | 2021-07-02 | 2021-07-06 | 3,938,387 | — | $0 | 4,179,854 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | P Buy | 2021-07-02 | 2021-07-06 | 2,785,714 | $14.00 | $39.00M | 6,965,568 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion | 2021-07-02 | 2021-07-06 | 311,170 | — | $0 | 311,170 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion | 2021-07-02 | 2021-07-06 | 987,244 | — | $0 | 987,244 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 18,044,028 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 12,643,557 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 856,262 | — | $0 | 856,262 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 599,987 | — | $0 | 1,456,249 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-02 | 825,000 | $17.00 | $14.03M | 2,281,249 | SEC↗ |